Literature DB >> 20388791

Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection.

Wei Lu1, Guodong Zhang, Rui Zhang, Leo G Flores, Qian Huang, Juri G Gelovani, Chun Li.   

Abstract

NF-kappaB transcription factor is a critical regulator of the expression of genes involved in tumor formation and progression. Successful RNA interference (RNAi) therapeutics targeting NF-kappaB is challenged by small interfering RNA (siRNA) delivery systems, which can render targeted in vivo delivery, efficient endolysosomal escape, and dynamic control over activation of RNAi. Here, we report near-IR (NIR) light-inducible NF-kappaB downregulation through folate receptor-targeted hollow gold nanospheres carrying siRNA recognizing NF-kappaB p65 subunit. Using micro-positron emission tomography/computed tomography imaging, the targeted nanoconstructs exhibited significantly higher tumor uptake in nude mice bearing HeLa cervical cancer xenografts than nontargeted nanoparticles following i.v. administration. Mediated by hollow gold nanospheres, controllable cytoplasmic delivery of siRNA was obtained on NIR light irradiation through photothermal effect. Efficient downregulation of NF-kappaB p65 was achieved only in tumors irradiated with NIR light but not in nonirradiated tumors grown in the same mice. Liver, spleen, kidney, and lung were not affected by the treatments, in spite of significant uptake of the siRNA nanoparticles in these organs. We term this mode of action "photothermal transfection." Combined treatments with p65 siRNA photothermal transfection and irinotecan caused substantially enhanced tumor apoptosis and significant tumor growth delay compared with other treatment regimens. Therefore, photothermal transfection of NF-kappaB p65 siRNA could effectively sensitize the tumor to chemotherapeutic agents. Because NIR light can penetrate the skin and be delivered with high spatiotemporal control, therapeutic RNAi may benefit from this novel transfection strategy while avoiding unwanted side effect. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388791      PMCID: PMC2856125          DOI: 10.1158/0008-5472.CAN-09-3379

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  A clearer vision for in vivo imaging.

Authors:  R Weissleder
Journal:  Nat Biotechnol       Date:  2001-04       Impact factor: 54.908

2.  Controlled release of plasmid DNA from gold nanorods induced by pulsed near-infrared light.

Authors:  Hironobu Takahashi; Yasuro Niidome; Sunao Yamada
Journal:  Chem Commun (Camb)       Date:  2005-03-09       Impact factor: 6.222

Review 3.  Intracellular trafficking of nonviral vectors.

Authors:  L K Medina-Kauwe; J Xie; S Hamm-Alvarez
Journal:  Gene Ther       Date:  2005-12       Impact factor: 5.250

4.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells.

Authors:  B Devika Chithrani; Arezou A Ghazani; Warren C W Chan
Journal:  Nano Lett       Date:  2006-04       Impact factor: 11.189

5.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity.

Authors:  Ellen E Connor; Judith Mwamuka; Anand Gole; Catherine J Murphy; Michael D Wyatt
Journal:  Small       Date:  2005-03       Impact factor: 13.281

6.  DNA-gold nanorod conjugates for remote control of localized gene expression by near infrared irradiation.

Authors:  Chia-Chun Chen; Yen-Ping Lin; Chih-Wei Wang; Hsiao-Chien Tzeng; Chia-Hsuan Wu; Yi-Cheng Chen; Chin-Pei Chen; Li-Chyong Chen; Yi-Chun Wu
Journal:  J Am Chem Soc       Date:  2006-03-22       Impact factor: 15.419

7.  Light controllable siRNAs regulate gene suppression and phenotypes in cells.

Authors:  Quan N Nguyen; Rajesh V Chavli; Joao T Marques; Peter G Conrad; Die Wang; Weihai He; Barbara E Belisle; Aiguo Zhang; Larry M Pastor; Frank R Witney; May Morris; Frederic Heitz; Gilles Divita; Bryan R G Williams; Gary K McMaster
Journal:  Biochim Biophys Acta       Date:  2006-01-30

Review 8.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

9.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

10.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice.

Authors:  Guodong Zhang; Zhi Yang; Wei Lu; Rui Zhang; Qian Huang; Mei Tian; Li Li; Dong Liang; Chun Li
Journal:  Biomaterials       Date:  2009-01-07       Impact factor: 12.479

View more
  78 in total

1.  FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERY.

Authors:  Gang Liu; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Nano Today       Date:  2010-12-01       Impact factor: 20.722

2.  Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.

Authors:  Jian You; Rui Zhang; Guodong Zhang; Meng Zhong; Yang Liu; Carolyn S Van Pelt; Dong Liang; Wei Wei; Anil K Sood; Chun Li
Journal:  J Control Release       Date:  2011-10-28       Impact factor: 9.776

3.  Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors.

Authors:  Wei Lu; Chiyi Xiong; Rui Zhang; Lifang Shi; Miao Huang; Guodong Zhang; Shaoli Song; Qian Huang; Gang-Yu Liu; Chun Li
Journal:  J Control Release       Date:  2012-05-14       Impact factor: 9.776

4.  In vivo imaging of T cells loaded with gold nanoparticles: a pilot study.

Authors:  Hui Li; Laura Diaz; Daniel Lee; Lei Cui; Xin Liang; Yingsheng Cheng
Journal:  Radiol Med       Date:  2013-12-06       Impact factor: 3.469

5.  RNA-guided diagnostics and therapeutics for next-generation individualized nanomedicine.

Authors:  Gennadi V Glinsky
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

6.  Research perspectives: gold nanoparticles in cancer theranostics.

Authors:  Junjie Li; Sanjay Gupta; Chun Li
Journal:  Quant Imaging Med Surg       Date:  2013-12

Review 7.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

8.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 9.  Challenges to effective cancer nanotheranostics.

Authors:  Marites P Melancon; R Jason Stafford; Chun Li
Journal:  J Control Release       Date:  2012-08-18       Impact factor: 9.776

10.  Challenges and opportunities in the advancement of nanomedicines.

Authors:  Alexander Wei; Jonathan G Mehtala; Anil K Patri
Journal:  J Control Release       Date:  2012-10-12       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.